Simplifying synthesis of the expanding glioblastoma literature: a topic modeling approach.
Glioblastoma
Hot topic
Natural language processing
Research trends
Topic modeling
Journal
Journal of neuro-oncology
ISSN: 1573-7373
Titre abrégé: J Neurooncol
Pays: United States
ID NLM: 8309335
Informations de publication
Date de publication:
11 Jul 2024
11 Jul 2024
Historique:
received:
20
05
2024
accepted:
28
06
2024
medline:
11
7
2024
pubmed:
11
7
2024
entrez:
11
7
2024
Statut:
aheadofprint
Résumé
Our study aims to discover the leading topics within glioblastoma (GB) research, and to examine if these topics have "hot" or "cold" trends. Additionally, we aim to showcase the potential of natural language processing (NLP) in facilitating research syntheses, offering an efficient strategy to dissect the landscape of academic literature in the realm of GB research. The Scopus database was queried using "glioblastoma" as the search term, in the "TITLE" and "KEY" fields. BERTopic, an NLP-based topic modeling (TM) method, was used for probabilistic TM. We specified a minimum topic size of 300 documents and 5% probability cutoff for outlier detection. We labeled topics based on keywords and representative documents and visualized them with word clouds. Linear regression models were utilized to identify "hot" and "cold" topic trends per decade. Our TM analysis categorized 43,329 articles into 15 distinct topics. The most common topics were Genomics, Survival, Drug Delivery, and Imaging, while the least common topics were Surgical Resection, MGMT Methylation, and Exosomes. The hottest topics over the 2020s were Viruses and Oncolytic Therapy, Anticancer Compounds, and Exosomes, while the cold topics were Surgical Resection, Angiogenesis, and Tumor Metabolism. Our NLP methodology provided an extensive analysis of GB literature, revealing valuable insights about historical and contemporary patterns difficult to discern with traditional techniques. The outcomes offer guidance for research directions, policy, and identifying emerging trends. Our approach could be applied across research disciplines to summarize and examine scholarly literature, guiding future exploration.
Identifiants
pubmed: 38990445
doi: 10.1007/s11060-024-04762-8
pii: 10.1007/s11060-024-04762-8
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.
Références
Ostrom QT, Price M, Neff C et al (2022) CBTRUS Statistical Report: primary brain and other Central Nervous System tumors diagnosed in the United States in 2015–2019. Neurooncology 24:v1–v95. https://doi.org/10.1093/neuonc/noac202
doi: 10.1093/neuonc/noac202
Thakkar JP, Dolecek TA, Horbinski C et al (2014) Epidemiologic and molecular prognostic review of glioblastoma. Cancer Epidemiol Biomarkers Prev 23:1985–1996. https://doi.org/10.1158/1055-9965.EPI-14-0275
doi: 10.1158/1055-9965.EPI-14-0275
pubmed: 25053711
pmcid: 4185005
Nieder C, Astner ST, Grosu AL (2012) Glioblastoma research 2006–2010: pattern of citation and systematic review of highly cited articles. Clin Neurol Neurosurg 114:1207–1210. https://doi.org/10.1016/j.clineuro.2012.03.049
doi: 10.1016/j.clineuro.2012.03.049
pubmed: 22516416
Akmal M, Hasnain N, Rehan A et al (2020) Glioblastome Multiforme: a bibliometric analysis. World Neurosurg 136:270–282. https://doi.org/10.1016/j.wneu.2020.01.027
doi: 10.1016/j.wneu.2020.01.027
pubmed: 31953095
Borah R, Brown AW, Capers PL, Kaiser KA (2017) Analysis of the time and workers needed to conduct systematic reviews of medical interventions using data from the PROSPERO registry. BMJ Open 7:e012545. https://doi.org/10.1136/bmjopen-2016-012545
doi: 10.1136/bmjopen-2016-012545
pubmed: 28242767
pmcid: 5337708
Pham MT, Rajić A, Greig JD et al (2014) A scoping review of scoping reviews: advancing the approach and enhancing the consistency. Res Syn Meth 5:371–385. https://doi.org/10.1002/jrsm.1123
doi: 10.1002/jrsm.1123
Brscic M, Contiero B, Schianchi A, Marogna C (2021) Challenging suicide, burnout, and depression among veterinary practitioners and students: text mining and topics modelling analysis of the scientific literature. BMC Vet Res 17:294. https://doi.org/10.1186/s12917-021-03000-x
doi: 10.1186/s12917-021-03000-x
pubmed: 34488757
pmcid: 8419380
Urru S, Sciannameo V, Lanera C et al (2022) A topic trend analysis on COVID-19 literature. Digit HEALTH 8:205520762211336. https://doi.org/10.1177/20552076221133696
doi: 10.1177/20552076221133696
Chowdhary KR (2020) Natural Language Processing. Fundamentals of Artificial Intelligence. Springer India, New Delhi, pp 603–649
doi: 10.1007/978-81-322-3972-7_19
Hirschberg J, Manning CD (2015) Advances in natural language processing. Science 349:261–266. https://doi.org/10.1126/science.aaa8685
doi: 10.1126/science.aaa8685
pubmed: 26185244
Gonzalez GH, Tahsin T, Goodale BC et al (2016) Recent advances and emerging applications in text and Data Mining for Biomedical Discovery. Brief Bioinform 17:33–42. https://doi.org/10.1093/bib/bbv087
doi: 10.1093/bib/bbv087
pubmed: 26420781
Blei DM (2012) Probabilistic topic models. Commun ACM 55:77–84. https://doi.org/10.1145/2133806.2133826
doi: 10.1145/2133806.2133826
Marshall IJ, Wallace BC (2019) Toward systematic review automation: a practical guide to using machine learning tools in research synthesis. Syst Rev 8(163) s13643-019-1074–9. https://doi.org/10.1186/s13643-019-1074-9
Grootendorst M (2022) BERTopic: Neural topic modeling with a class-based TF-IDF procedure. In: arXiv.org. https://arxiv.org/abs/2203.05794v1 . Accessed 13 May 2023
Devlin J, Chang M-W, Lee K, Toutanova K (2019) BERT: Pre-training of Deep Bidirectional Transformers for Language Understanding. In: Proceedings of the 2019 Conference of the North. Association for Computational Linguistics, Minneapolis, Minnesota, pp 4171–4186
Deka P, Jurek-Loughrey A, Padmanabhan D (2022) Improved methods to aid unsupervised evidence-based fact checking for online health news. J Data Intell 3:474–505. https://doi.org/10.26421/JDI3.4-5
doi: 10.26421/JDI3.4-5
Bird S, Klein E, Loper E (2009) Natural language processing with Python: analyzing text with the natural language toolkit
Bittermann A, Fischer A (2018) How to identify hot topics in psychology using topic modeling. Z Psychol 226:3–13. https://doi.org/10.1027/2151-2604/a000318
doi: 10.1027/2151-2604/a000318
Watanabe G, Conching A, Nishioka S et al (2023) Themes in neuronavigation research: a machine learning topic analysis. World Neurosurgery: X 18:100182. https://doi.org/10.1016/j.wnsx.2023.100182
doi: 10.1016/j.wnsx.2023.100182
pubmed: 37013107
Sing DC, Metz LN, Dudli S (2017) Machine learning-based classification of 38 years of spine-related literature into 100 Research Topics. Spine (Phila Pa 1976) 42:863–870. https://doi.org/10.1097/BRS.0000000000002079
doi: 10.1097/BRS.0000000000002079
pubmed: 28125523
Fan G, Li Y, Yang S et al (2023) Research topics and hotspot trends of lumbar spondylolisthesis: a text-mining study with machine learning. Front Surg 9:1037978. https://doi.org/10.3389/fsurg.2022.1037978
doi: 10.3389/fsurg.2022.1037978
pubmed: 36684199
pmcid: 9852633
Blei DM, Ng AY, Jordan MI (2003) Latent Dirichlet Allocation. J Mach Learn Res 3:993–1022
Jain S, Wallace BC (2019) Attention is not Explanation. https://doi.org/10.48550/ARXIV.1902.10186
Gilpin LH, Bau D, Yuan BZ et al (2018) Explaining Explanations: An Overview of Interpretability of Machine Learning. In: 2018 IEEE 5th International Conference on Data Science and Advanced Analytics (DSAA). IEEE, Turin, Italy, pp 80–89
Cancer Genome Atlas Research Network, Brat DJ, Verhaak RGW et al (2015) Comprehensive, Integrative Genomic Analysis of Diffuse Lower-Grade Gliomas. N Engl J Med 372:2481–2498. https://doi.org/10.1056/NEJMoa1402121
doi: 10.1056/NEJMoa1402121
The Cancer Genome Atlas Research Network (2008) Comprehensive genomic characterization defines human glioblastoma genes and core pathways. Nature 455:1061–1068. https://doi.org/10.1038/nature07385
doi: 10.1038/nature07385
Parsons DW, Jones S, Zhang X et al (2008) An Integrated Genomic Analysis of Human Glioblastoma Multiforme. Science 321:1807–1812. https://doi.org/10.1126/science.1164382
doi: 10.1126/science.1164382
pubmed: 18772396
pmcid: 2820389
Steponaitis G, Tamasauskas A (2021) Mesenchymal and proneural subtypes of Glioblastoma disclose branching based on GSC Associated Signature. IJMS 22:4964. https://doi.org/10.3390/ijms22094964
doi: 10.3390/ijms22094964
pubmed: 34066996
pmcid: 8124327
Crespo I, Vital AL, Gonzalez-Tablas M et al (2015) Molecular and genomic alterations in Glioblastoma Multiforme. Am J Pathol 185:1820–1833. https://doi.org/10.1016/j.ajpath.2015.02.023
doi: 10.1016/j.ajpath.2015.02.023
pubmed: 25976245
Patel AP, Tirosh I, Trombetta JJ et al (2014) Single-cell RNA-seq highlights intratumoral heterogeneity in primary glioblastoma. Science 344:1396–1401. https://doi.org/10.1126/science.1254257
doi: 10.1126/science.1254257
pubmed: 24925914
pmcid: 4123637
Francis JM, Zhang C-Z, Maire CL et al (2014) EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. Cancer Discov 4:956–971. https://doi.org/10.1158/2159-8290.CD-13-0879
doi: 10.1158/2159-8290.CD-13-0879
pubmed: 24893890
pmcid: 4125473
Hegi ME, Diserens A-C, Gorlia T et al (2005) MGMT gene silencing and benefit from temozolomide in glioblastoma. N Engl J Med 352:997–1003. https://doi.org/10.1056/NEJMoa043331
doi: 10.1056/NEJMoa043331
pubmed: 15758010
Chandler KL, Prados MD, Malec M, Wilson CB (1993) Long-term survival in patients with glioblastoma multiforme. Neurosurgery 32:716–720 discussion 720. https://doi.org/10.1227/00006123-199305000-00003
doi: 10.1227/00006123-199305000-00003
pubmed: 8388081
Lacroix M, Abi-Said D, Fourney DR et al (2001) A multivariate analysis of 416 patients with glioblastoma multiforme: prognosis, extent of resection, and survival. J Neurosurg 95:190–198. https://doi.org/10.3171/jns.2001.95.2.0190
doi: 10.3171/jns.2001.95.2.0190
pubmed: 11780887
Stummer W, Pichlmeier U, Meinel T et al (2006) Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial. Lancet Oncol 7:392–401. https://doi.org/10.1016/S1470-2045(06)70665-9
doi: 10.1016/S1470-2045(06)70665-9
pubmed: 16648043
Stupp R, Tonn J-C, Brada M, Pentheroudakis G (2010) High-grade malignant glioma: ESMO Clinical Practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 21:v190–v193. https://doi.org/10.1093/annonc/mdq187
doi: 10.1093/annonc/mdq187
pubmed: 20555079
Anderson E, Grant R, Lewis SC, Whittle IR (2008) Randomized Phase III controlled trials of therapy in malignant glioma: where are we after 40 years? Br J Neurosurg 22:339–349. https://doi.org/10.1080/02688690701885603
doi: 10.1080/02688690701885603
pubmed: 18568722
Adeberg S, Bostel T, König L et al (2014) A comparison of long-term survivors and short-term survivors with glioblastoma, subventricular zone involvement: a predictive factor for survival? Radiat Oncol 9:95. https://doi.org/10.1186/1748-717X-9-95
doi: 10.1186/1748-717X-9-95
pubmed: 24758192
pmcid: 4011838
Arvanitis CD, Ferraro GB, Jain RK (2020) The blood-brain barrier and blood-tumour barrier in brain tumours and metastases. Nat Rev Cancer 20:26–41. https://doi.org/10.1038/s41568-019-0205-x
doi: 10.1038/s41568-019-0205-x
pubmed: 31601988
Sarkaria JN, Hu LS, Parney IF et al (2018) Is the blood-brain barrier really disrupted in all glioblastomas? A critical assessment of existing clinical data. Neuro Oncol 20:184–191. https://doi.org/10.1093/neuonc/nox175
doi: 10.1093/neuonc/nox175
pubmed: 29016900
Heffron TP (2018) Challenges of developing small-molecule kinase inhibitors for brain tumors and the need for emphasis on free drug levels. Neuro Oncol 20:307–312. https://doi.org/10.1093/neuonc/nox179
doi: 10.1093/neuonc/nox179
pubmed: 29016919
Vivanco I, Robins HI, Rohle D et al (2012) Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov 2:458–471. https://doi.org/10.1158/2159-8290.CD-11-0284
doi: 10.1158/2159-8290.CD-11-0284
pubmed: 22588883
pmcid: 3354723
Wen PY, Cloughesy TF, Olivero AG et al (2020) First-in-human phase I study to evaluate the brain-penetrant PI3K/mTOR inhibitor GDC-0084 in patients with Progressive or Recurrent High-Grade Glioma. Clin Cancer Res 26:1820–1828. https://doi.org/10.1158/1078-0432.CCR-19-2808
doi: 10.1158/1078-0432.CCR-19-2808
pubmed: 31937616
Drappatz J, Brenner A, Wong ET et al (2013) Phase I study of GRN1005 in recurrent malignant glioma. Clin Cancer Res 19:1567–1576. https://doi.org/10.1158/1078-0432.CCR-12-2481
doi: 10.1158/1078-0432.CCR-12-2481
pubmed: 23349317
Idbaih A, Canney M, Belin L et al (2019) Safety and feasibility of repeated and transient blood-brain barrier disruption by Pulsed Ultrasound in patients with recurrent glioblastoma. Clin Cancer Res 25:3793–3801. https://doi.org/10.1158/1078-0432.CCR-18-3643
doi: 10.1158/1078-0432.CCR-18-3643
pubmed: 30890548
Terrível M, Gromicho C, Matos AM (2020) Oncolytic viruses: what to expect from their use in cancer treatment. Microbiol Immunol 64:477–492. https://doi.org/10.1111/1348-0421.12753
doi: 10.1111/1348-0421.12753
pubmed: 31663631
Hamad A, Yusubalieva GM, Baklaushev VP et al (2023) Recent developments in Glioblastoma Therapy: oncolytic viruses and emerging future strategies. Viruses 15:547. https://doi.org/10.3390/v15020547
doi: 10.3390/v15020547
pubmed: 36851761
pmcid: 9958853
Germano IM, Fable J, Gultekin SH, Silvers A (2003) Adenovirus/herpes simplex-thymidine kinase/ganciclovir complex: preliminary results of a phase I trial in patients with recurrent malignant gliomas. J Neurooncol 65:279–289. https://doi.org/10.1023/b:neon.0000003657.95085.56
doi: 10.1023/b:neon.0000003657.95085.56
pubmed: 14682378
Wollmann G, Ozduman K, Van Den Pol AN (2012) Oncolytic virus therapy for Glioblastoma Multiforme: concepts and candidates. Cancer J 18:69–81. https://doi.org/10.1097/PPO.0b013e31824671c9
doi: 10.1097/PPO.0b013e31824671c9
pubmed: 22290260
pmcid: 3632333
Germano IM, Ziu M, Wen P et al (2022) Congress of Neurological Surgeons systematic review and evidence-based guidelines update on the role of cytotoxic chemotherapy and other cytotoxic therapies in the management of progressive glioblastoma in adults. J Neurooncol 158:225–253. https://doi.org/10.1007/s11060-021-03900-w
doi: 10.1007/s11060-021-03900-w
pubmed: 35195819
Valadi H, Ekström K, Bossios A et al (2007) Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 9:654–659. https://doi.org/10.1038/ncb1596
doi: 10.1038/ncb1596
pubmed: 17486113
Akers JC, Ramakrishnan V, Kim R et al (2013) miR-21 in the Extracellular vesicles (EVs) of Cerebrospinal Fluid (CSF): a platform for Glioblastoma Biomarker Development. PLoS ONE 8:e78115. https://doi.org/10.1371/journal.pone.0078115
doi: 10.1371/journal.pone.0078115
pubmed: 24205116
pmcid: 3804457
Saadatpour L, Fadaee E, Fadaei S et al (2016) Glioblastoma: exosome and microRNA as novel diagnosis biomarkers. Cancer Gene Ther 23:415–418. https://doi.org/10.1038/cgt.2016.48
doi: 10.1038/cgt.2016.48
pubmed: 27834360